DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
58 hedge funds and large institutions have $40.7M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
58
Holding in Top 10
–
Calls
$2.64M
Puts
–
Top Buyers
| 1 | +$9.61M | |
| 2 | +$3.05M | |
| 3 | +$2.16M | |
| 4 |
ICM
Ionic Capital Management
New York
|
+$1.7M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.7M |
Top Sellers
| 1 | -$5.58M | |
| 2 | -$3.67M | |
| 3 | -$1.36M | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$630K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$560K |